Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr
Products

Rossari Biotech plans to acquire Tristar Intermediates for Rs 120 cr

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches.

Rossari Biotech said that the acquisition will occur in multiple tranches.

It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025.

As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing.

Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run.

Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997.

It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA).

It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year.

Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal.

Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year.

Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round.

Image Source

Rossari Biotech Limited, a specialty chemicals manufacturer, told the media that it has agreed to acquire Tristar Intermediates Pvt Ltd for Rs 120 crore in multiple tranches. Rossari Biotech said that the acquisition will occur in multiple tranches. It will acquire a 76% equity stake of Tristar by September this year, as part of the first tranche, and the remaining will be acquired by the financial ending March 31, 2025. As part of its inorganic growth plan, the acquisition is in line with Rossari Biotech's strategy to set its place in specialty chemicals manufacturing. Tristar allows synergies in manufacturing and marketing that can be highly valued accretive in the long run. Tristar is involved in the manufacture and trade of organic and inorganic chemicals and was incorporated on September 1, 1997. It has three manufacturing plants with a capability of 15,000 million tonnes per annum (MTPA). It had registered a turnover of Rs 110.5 crore in the last financial year 2020-21 against Rs 95.2 crore in the prior fiscal year. Rossari Biotech announced last month that it will buy Unitop Chemicals Private for Rs 421 crore in an all-cash deal. Marking its first initial public offering (IPO) since India went into a lockdown in late March to manage the pandemic, Rossari went public in July last year. Before that, the company had raised Rs 100 crore by allocating shares to eight institutional investors in a pre-initial public offering (IPO) round. Image Source

Next Story
Infrastructure Transport

Kavach 4.0 Commissioned on Delhi–Mumbai and Delhi–Howrah

"Kavach version four has been commissioned on 1,452 route km, covering the high density Delhi–Mumbai and Delhi–Howrah corridors. The rollout included laying 8,570 km of optical fibre, installation of 1,100 telecom towers, deployment of trackside equipment over 6,776 RKm and establishment of 767 station data centres. Trackside implementation has been taken up on 24,427 RKm covering Golden Quadrilateral, Golden Diagonal and High Density Network sections. The programme aims to strengthen signalling and train protection on key routes.Kavach is an indigenously developed automatic train protecti..

Next Story
Infrastructure Transport

Railways Advance Kalyan–Murbad Line And Mumbai Capacity Expansion

"Indian Railways is advancing multiple rail infrastructure projects in Maharashtra, including the sanctioned Kalyan–Murbad new line and sizable investments under the Mumbai Urban Transport Project and the Mumbai–Ahmedabad High Speed Rail project. The Kalyan–Murbad 28 km new line has been sanctioned at Rs 8.36 billion (bn) on a 50:50 cost-sharing basis with the Government of Maharashtra and has been declared a Special Railway Project for land acquisition; proposals covering 214 hectares are at various stages of acquisition. Budgetary outlay for projects falling fully or partly in Maharash..

Next Story
Infrastructure Urban

Parliamentary Panel Flags Funding Gaps in Heavy Industries

"The Department-Related Parliamentary Standing Committee on Industry (Rajya Sabha) presented its 332nd report on the Demands for Grants 2026-27 of the Ministry of Heavy Industries (MHI). Figures converted from crore and lakh are expressed in million (mn). The Budget Estimates 2026-27 for the Ministry stand at Rs 79,399 mn against a projected requirement of Rs 94,843.2 mn, a shortfall of about 16 per cent, with revenue at Rs 79,370.8 mn and capital compressed to Rs 28.2 mn from Rs 5,020 mn.The committee flagged recurring BE-to-RE compression and declining revised estimate utilisation, and calle..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement